<\/p>\n
Edit:\u00a0 maher badr<\/p>\n
<\/p>\n
Inaugurates New Scientific Office in Cairo to Support Healthcare
\nAstellas Pharma Egypt today inaugurated its new scientific office in Cairo, marking an important milestone in the company\u2019s journey in the Egyptian market and reflecting its long-term commitment to the healthcare sector in Egypt.<\/p>\n
<\/p>\n
The opening of the new office comes as part of Astellas Pharma\u2019s commitment to strengthening its engagement with the Egyptian healthcare ecosystem and continuing to work closely with various stakeholders, contributing to addressing patients\u2019 needs and supporting the continued development of the healthcare sector in Egypt.<\/p>\n
<\/p>\n
The inauguration ceremony was attended by H.E. Mr. Iwai Fumio, Ambassador Extraordinary and Plenipotentiary of Japan to the Arab Republic of Egypt, alongside representatives of the Embassy of Japan and the Japan External Trade Organization (JETRO), including Mr. Takaki Harashima, Second Secretary at the Embassy of Japan in the Arab Republic of Egypt, and Mr. Shigeyo Nishizawa, Director General of the Japan External Trade Organization (JETRO) \u2013 Cairo Office.<\/p>\n
<\/p>\n
The ceremony was also attended by Mr. Ricardo Ogawa, President, International Markets at Astellas Pharma; Ms. Seyma Bahsi, Head of Turkey, Middle East and Africa (TMEA) at Astellas Pharma; and Ms. Sunny Lee, General Manager of Astellas Pharma Egypt, along with a number of representatives from the healthcare sector and medical community.<\/p>\n
<\/p>\n
Ms. Sunny Lee, General Manager of Astellas Pharma Egypt, said that the opening of the new scientific office represents an important milestone in the company\u2019s journey in Egypt and reflects its long-term commitment to the Egyptian market and the patients it serves.
\nShe added that the new office strengthens Astellas Pharma\u2019s engagement with various stakeholders across the healthcare ecosystem and provides the company with an opportunity to deepen collaboration and contribute to the continued development of the healthcare system in Egypt.
\nShe emphasized that Astellas Pharma believes that achieving meaningful progress in healthcare requires innovation, collaboration, and strong partnerships, noting the company\u2019s aspiration to continue working closely with its partners in Egypt to help address unmet medical needs and create meaningful value for patients and society.<\/p>\n
<\/p>\n
The event highlighted the longstanding relationship between Egypt and Japan and the importance of continued cooperation between the two countries across areas including healthcare, innovation, and economic development.
\nThe event also featured a ribbon-cutting ceremony attended by H.E. Mr. Iwai Fumio, Ambassador Extraordinary and Plenipotentiary of Japan to the Arab Republic of Egypt; Mr. Ricardo Ogawa, President, International Markets at Astellas Pharma; Ms. Seyma Bahsi, Head of Turkey, Middle East and Africa (TMEA) at Astellas Pharma; and Ms. Sunny Lee, General Manager of Astellas Pharma Egypt, marking the official opening of the new scientific office.<\/p>\n
<\/p>\n
The opening of the office marks a new chapter in Astellas Pharma Egypt\u2019s journey and reaffirms the company\u2019s commitment to continued collaboration, innovation, and stronger engagement with Egypt\u2019s healthcare community.
\nAbout Astellas<\/p>\n
Astellas Pharma is a global Japanese life sciences company committed to turning innovative science into value for patients, with a focus on developing innovative therapies in areas with significant unmet medical needs. www.astellas.com\u2060\ufffd
\nCautionary Notes<\/p>\n
This press release contains statements relating to current plans, estimates, strategies, beliefs, and other statements that are not historical facts and constitute forward-looking statements regarding Astellas\u2019 future performance. These statements are based on management\u2019s current assumptions and beliefs in light of information currently available to them and involve known and unknown risks and uncertainties. A number of factors could cause actual results to differ materially from those expressed in the forward-looking statements. These factors include, but are not limited to: (1) changes in general economic conditions and laws and regulations relating to pharmaceutical markets; (2) fluctuations in foreign exchange rates; (3) delays in the launch of new products; (4) Astellas\u2019 inability to effectively market its existing and new products; (5) Astellas\u2019 inability to continue effective research and development of products that achieve customer acceptance in highly competitive markets; and (6) infringement of Astellas\u2019 intellectual property rights by third parties.
\nInformation relating to pharmaceutical products, including products still under development, contained in this press release is not intended to constitute an advertisement or medical advice<\/p>\n","protected":false},"excerpt":{"rendered":"
Edit:\u00a0 maher badr Inaugurates New Scientific Office in Cairo to Support Healthcare Astellas Pharma Egypt today inaugurated its new scientific office in Cairo, marking an important milestone in the company\u2019s journey in the Egyptian market and reflecting its long-term commitment to the healthcare sector in Egypt. The opening of the new office …<\/p>\n","protected":false},"author":2,"featured_media":11943,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[1683,1682],"class_list":["post-11942","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-astellas-pharma-egypt","tag-in-the-presence-of-the-ambassador-of-japan"],"yoast_head":"\n